Second Genome and Mayo Clinic Partner for Microbiome Treatment Research

Second Genome and Mayo Clinic Partner for Microbiome Treatment Research
Research into some of the world’s most prevalent and deadly gastrointestinal disease is set to take a new turn in researching and developing a new class of therapeutics. A new collaboration has just been announced between leader in micro biome medicine, Second Genome, and the Mayo Clinic Center for Individualized Medicine. The two companies will be cooperating on research

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *